Reverse Phenotyping after Whole-Exome Sequencing in Children with Developmental Delay/Intellectual Disability-An

Nikola Ilic1, Nina Maric2, Ales Maver3

  • 1Clinical Genetics Outpatient Clinic, Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic", 11070 Belgrade, Serbia.

Genes
|June 27, 2024
PubMed

Insights

Whole-exome sequencing (WES) diagnosed 66% of pediatric developmental delay/intellectual disability (DD/ID) cases. Reverse phenotyping (RP) proved crucial for complex diagnoses, especially when WES was initially negative.

Area of Science:

  • Clinical Genetics
  • Genomics
  • Pediatric Neurology

Background:

  • Developmental delay/intellectual disability (DD/ID) presents a significant diagnostic challenge in pediatrics.
  • Identifying the genetic etiology of DD/ID is crucial for accurate diagnosis, prognosis, and management.
  • Traditional genetic testing methods may not always yield a diagnosis in complex cases.

Purpose of the Study:

  • To evaluate the diagnostic yield of whole-exome sequencing (WES) in pediatric patients with DD/ID.
  • To assess the utility of Reverse Phenotyping (RP) in refining diagnoses, particularly in cases with prior negative genetic testing.
  • To explore the predictive capabilities of neural network models for WES and RP patient selection.

Main Methods:

  • Whole-exome sequencing (WES) was performed on a cohort of 100 pediatric patients with DD/ID.
  • Reverse Phenotyping (RP) was applied to analyze WES data and clinical information.
  • Neural network models were developed to predict the likelihood of successful WES and RP.

Main Results:

  • WES achieved a diagnostic yield of 66% in the study cohort.
  • RP was instrumental in diagnosing cases with initially negative genetic testing and was indicated in 50% of positive WES findings.
  • Genetic conditions identified showed significant heterogeneity, highlighting diverse etiological factors.
  • Neural networks demonstrated moderate to exceptional predictive performance for patient selection.

Conclusions:

  • WES is an effective diagnostic tool for pediatric DD/ID, especially when metabolic abnormalities are present.
  • RP significantly enhances diagnostic capabilities, particularly in complex and previously undiagnosed cases.
  • Integrating WES, RP, and predictive modeling offers a comprehensive approach to understanding the genetic landscape of DD/ID, improving patient management and genetic counseling.